These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10745507)

  • 1. Percutaneous transluminal myocardial revascularization: an emerging technology.
    Shawl FA
    J Invasive Cardiol; 1999 Mar; 11(3):169-75; discussion 175-6. PubMed ID: 10745507
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmyocardial revascularization: an industry perspective.
    Ahern JE
    J Invasive Cardiol; 1999 Mar; 11(3):192-4. PubMed ID: 10745510
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.
    Celik T; Iyisoy A; Yuksel UC; Isik E
    Int J Cardiol; 2009 Jan; 131(2):269-70; author reply 271-2. PubMed ID: 17692947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Revascularization Therapies Study (ARTS).
    Indian Heart J; 2001; 53(2):239. PubMed ID: 11428490
    [No Abstract]   [Full Text] [Related]  

  • 5. [The results of endovascular and surgical myocardial revascularization in patients with type II diabetes mellitus].
    ArablinskiÄ­ AV; Ovesian ZR; Kulikov AV; Shanoian AS
    Klin Med (Mosk); 2005; 83(5):14-8. PubMed ID: 15984575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetic retinopathy as a guide for treatment strategy in coronary revascularization: from the perspective of cardiac surgeons].
    Ohno T; Takamoto S
    J Cardiol; 2007 May; 49(5):259-66. PubMed ID: 17552291
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete revascularization: coronary artery bypass graft surgery versus percutaneous coronary intervention.
    Ong AT; Serruys PW
    Circulation; 2006 Jul; 114(3):249-55. PubMed ID: 16847164
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete myocardial revascularization: between myth and reality.
    Zimarino M; Calafiore AM; De Caterina R
    Eur Heart J; 2005 Sep; 26(18):1824-30. PubMed ID: 15824076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter by Joshi regarding article, "Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy".
    Joshi SB
    Circulation; 2008 Dec; 118(25):e838; author reply e840-1. PubMed ID: 19106385
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in coronary angioplasty.
    Bittl JA
    N Engl J Med; 1996 Oct; 335(17):1290-302. PubMed ID: 8857010
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Tarantini et al regarding article, "Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy".
    Tarantini G; Razzolini R; Iliceto S
    Circulation; 2008 Dec; 118(25):e839; author reply e840-1. PubMed ID: 19106386
    [No Abstract]   [Full Text] [Related]  

  • 13. More on treatment for refractory angina.
    Paz Y; Shinfeld A
    Minn Med; 2009 Sep; 92(9):6; author reply 6. PubMed ID: 19877467
    [No Abstract]   [Full Text] [Related]  

  • 14. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial.
    Martuscelli E; Clementi F; Gallagher MM; D'Eliseo A; Chiricolo G; Nigri A; Marino B; Romeo F;
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):4-8. PubMed ID: 17988889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification for complete revascularisation at the time of primary angioplasty.
    Malik IS; Gerber RT
    Heart; 2010 May; 96(9):652-3. PubMed ID: 20424145
    [No Abstract]   [Full Text] [Related]  

  • 16. [Has the time come for hybrid revascularisation in multivessel coronary artery disease?].
    Zembala M; Tajstra M; Zembala M; Filipiak K; Hrapkowicz T; Kalarus Z; Poloński L; Gasior M
    Kardiol Pol; 2009 Jul; 67(7):817-22. PubMed ID: 19650010
    [No Abstract]   [Full Text] [Related]  

  • 17. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 18. How to overcome difficulties in the evaluation of best possible decision-making in redo-revascularization?
    Osswald BR
    Eur Heart J; 2006 Feb; 27(4):375-6. PubMed ID: 16311235
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute coronary syndromes: direct stent for all?
    Loubeyre C; Morice MC
    J Invasive Cardiol; 2002 Jun; 14(6):313-4. PubMed ID: 12042622
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous transluminal myocardial revascularization. A new treatment for angina.
    Dudek AA
    Crit Care Nurs Clin North Am; 1999 Sep; 11(3):327-32. PubMed ID: 10786479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.